Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Access, SpePharm in European MuGard pact

This article was originally published in Clinica

Executive Summary

Dallas, Texas-based Access Pharmaceuticals has signed an agreement which will see its oral wound rinse product MuGard marketed in Europe by Dutch company SpePharm. The agreement incorporates the European Union plus Switzerland, Norway and Iceland, and will see SpePharm become responsible for manufacturing and regulatory approval of the product within this territory.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049621

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel